Quinhub 300 Tablet contains Hydroxychloroquine 300mg, an antimalarial and immunomodulatory agent used for malaria prevention and treatment, as well as management of autoimmune disorders such as rheumatoid arthritis and systemic lupus erythematosus.
The tablet works by interfering with parasite growth in malaria and modulating the immune response in autoimmune conditions, reducing inflammation, pain, and disease progression.
Quinhub 300 Tablet belongs to the antimalarial and immunosuppressive segment, commonly prescribed by general physicians, rheumatologists, and infectious disease specialists.
For PCD pharma franchise partners, wholesalers, and exporters, Quinhub 300 Tablet provides a lucrative business opportunity due to its high demand in malaria-endemic regions and chronic autoimmune treatment markets. It is available for bulk supply, monopoly-based franchise, third-party manufacturing, institutional distribution, and export, ensuring profitable market presence and recurring demand.